Antimicrobial agents from microbial genomes

1. A method for identifying antimicrobial genes in a genome comprising the steps of:

(a) inserting genomic fragments of a genome into cloning vectors;

(b) introducing the cloning vectors that comprises the inserted genomic fragments to a host microorganism;

(c) cultivating the host microorganism that comprises the cloning vectors with the inserted genomic fragments to obtain a library of clones of the genome, wherein each clone comprises a genomic fragment of the genome, and wherein the genomic fragment in each clone does not comprise the full sequence of a gene toxic to the host microorganism or comprises an immunity gene if the genomic fragment comprises a gene toxic to the host microorganism;

(d) obtaining clone sequence reads of the genome by sequencing the library of clones;

(e) mapping said clone sequence reads onto the full sequence of the genome to identify clone positions on the full sequence of the genome;

(f) calculating clone coverage for each clone position of the genome, wherein the number of covering clones or clones that span each position is calculated, wherein the clone positions mapped to repetitive genomic sequences of the genome is excluded from the calculation;

(g) identifying genomic regions having no clone coverage and genomic regions having a statistically significant low clone coverage as compared to the other genomic regions of the genome;

(h) marking said genomic regions having no or low clone coverage as containing candidate toxic genes, wherein said toxic genes encode one or more protein or RNA molecules having antimicrobial activity;

(i) cloning one or more of said candidate toxic genes into a vector that contains an inducible promoter to produce protein or RNA gene product for each of the one or more of the candidate toxic genes; and

(j) determining an antimicrobial effect of the protein or RNA gene product of the one or more candidate toxic genes based on the inhibitory activity of the gene product on the growth of one or more bacteria.

2. The method of claim 1 , further comprising repeating steps (a) through (j) for two or more finished genomes.

3. The method of claim 1 , wherein said candidate toxic genes comprises one or more of the genes provided in Table 1.

4. The method of claim 1 , wherein said protein or RNA gene product has an antimicrobial activity against a microbe selected from the group consisting of Staphylococcus aureus , microorganisms of the genus Staphylococcus, Escherichia coli , microorganisms of the genus Escherichia , microorganisms of the genus Aspergillus , microorganisms of the genus Candida , microorganisms of the genus Mucor , microorganisms of the genus Absidia , microorganisms of the genus Cryptococcus , microorganisms of the genus Blastomyces , microorganisms of the genus Paracoccidioides , microorganisms of the genus Coccidioides , microorganisms of the genus Sporothrix, microorganisms of the genus Phialophora , microorganisms of the genus Histoplasma , microorganisms of the genus Trichophyton , microorganisms of the genus Microsporum , microorganisms of the genus Epidermophyton , microorganisms of the genus Bacillus , and microorganisms of the genus Yersinia , microorganisms of the genus Salmonella , and microorganisms of the genus Francisella.

5. The method of claim 1 , wherein expressing one or more of the candidate toxic genes comprises expressing the gene in an in vitro transcription/translation system to produce cell-free protein product.

6. The method of claim 1 , wherein said protein or RNA gene product is bactericidal or bacteriostatic.

7. The method of claim 1 , wherein said protein or RNA gene product has an antimicrobial effect on one or more plant pathogenic microorganisms.

8. The method of claim 1 , wherein the genomic regions having no clone coverage and low clone coverage in step (g) do not comprises self-folding or low complexity DNA.